telbivudine has been researched along with Myalgia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, BL; Lai, HS; Lee, CY; Tsai, MK; Yang, CY; Yang, YW | 1 |
| Liu, H; Wang, YH; Wu, BQ | 1 |
1 review(s) available for telbivudine and Myalgia
| Article | Year |
|---|---|
Continuous venovenous hemodiafiltration for hyperlactatemia caused by telbivudine in a patient with chronic hepatitis B: a case report and update review.
Topics: Adult; Antiviral Agents; Biomarkers; Creatine Kinase; Hemodiafiltration; Hepatitis B, Chronic; Humans; Hyperlactatemia; Male; Myalgia; Telbivudine; Thymidine | 2015 |
1 trial(s) available for telbivudine and Myalgia
| Article | Year |
|---|---|
Telbivudine for renal transplant recipients with chronic hepatitis B infection: a randomized controlled trial with early termination.
Topics: Adult; Aged; Antiviral Agents; Creatinine; Early Termination of Clinical Trials; Female; Glomerular Filtration Rate; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Male; Middle Aged; Myalgia; Prospective Studies; Telbivudine; Time Factors | 2020 |